Latest news for CA Immobilien Anlagen (OTC:CAIAF) Stock

CA Immobilien Anlagen AG is a real estate company involved in owning, developing and managing, especially office properties in Austria and Germany as well as in Eastern Europe. The company generates revenues and other income from rental activities, the sale of properties held for trading, the sale of properties as well as from development services. The company has two segments: Eastern Europe core region segment that consists of Poland and Czechia and Eastern Europe other region segment that consists of Hungary and Serbia.

CA IMMOBILIEN ANLAGEN AG by CA Immobilien Anlagen AG

CA Immobilien Anlagen AG

WIIM

AEHR

AMKR

CAMT

CRDO

INTC

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MKSI

MTSI

NVMI

ONTO

SITM

SMTC

SWKS

Shares of semiconductor companies are trading higher amid overall market strength following Wednesday's Fed rate cut.

Raymond James analyst Stephen Laws maintains Franklin BSP Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FBRT#NYSE">FBRT</a>) with a Strong Buy and raises the price target from $15 to $15.5.

News

Price Target

Analyst Ratings

FBRT

Raymond James Maintains Strong Buy on Franklin BSP Realty Trust, Raises Price Target to $15.5

ADBE

AEYE

AILE

AIRE

AIXI

ASAN

BILL

CDNS

CRWD

DAVE

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

HUBS

INTU

MNDY

PCOR

SLNH

SNPS

Shares of software companies are trading higher amid overall market strength following Wednesday's Fed rate cut.

Raymond James analyst Stephen Laws maintains Arbor Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABR#NYSE">ABR</a>) with a Outperform and raises the price target from $15 to $16.

Raymond James Maintains Outperform on Arbor Realty Trust, Raises Price Target to $16

Jay Emmanuel-Thomas, a former striker for football/soccer club Arsenal, has been charged following an alleged attempt to smuggle £600,000 ($796,794) worth of <a href="https://www.benzinga.com/cannabis">cannabis</a> into the UK through Stansted Airport. As The Telegraph <a href="https://www.telegraph.co.uk/football/2024/09/19/jay-emmanuel-thomas-arsenal-cannabis-stansted-airport/?ICID=continue_without_subscribing_reg_first">reported</a>, the 33-year-old, who currently plays for Greenock Morton in the Scottish Championship, was arrested by National Crime Agency (NCA) officers on Wednesday in Gourock, Inverclyde.
What Happened: The arrest came after Border Force officers reportedly discovered approximately 60kg (132 lbs) of cannabis, a Class B drug in the UK's controlled drug list, in two suitcases that had arrived on a flight from Bangkok, Thailand, on September 2. The NCA estimated the haul to be worth £600,000.
Emmanuel-Thomas, who once played for Ipswich Town, Queens Park Rangers and Bristol City, as well as Arsenal at youth level, was detained and questioned by officers before being remanded in custody. He is expected to appear before Carlisle Magistrates Court on Thursday.
See Also: <a href="https://www.benzinga.com/markets/cannabis/24/09/40798855/uk-government-drug-ban-targets-zombie-drug-xylazine-and-other-opioids">UK Government Drug Ban Targets &#8216;Zombie Drug&#8217; Xylazine And Other Opioids</a>
<h3 class="wp-block-heading">NCA And Border Force Joint Efforts</h3>
David Phillips, NCA's senior investigating officer, said, "The NCA continues to work with partners like Border Force to target those involved in drug smuggling – that includes both the couriers and the organizers." He also urged individuals approached to engage in such activities to "think very carefully about the likely consequences of their actions and the potentially life-changing risks they will be taking."
This arrest follows a sharp increase in the amount of cannabis being seized at U.K. borders, particularly from travelers arriving from Thailand, Canada and the United States. The NCA has warned that drug couriers are often misled by superiors into believing they face only fines if caught, though the maximum sentence for smuggling cannabis into the UK is 14 years in prison.
Now Read: <a href="https://www.benzinga.com/news/large-cap/24/08/40099281/bank-of-england-reduces-16-year-high-interest-rates-in-divided-decision-as-inflation-hits-2">Bank Of England Reduces 16-Year High Interest Rates In Divided Decision As Inflation Hits 2%</a>
Cover image made with AI

Cannabis

Former Premier League Player Charged After Allegedly Trying To Smuggle 60 Kg (132 Lbs) Of Cannabis Into UK

ALLY

ARES

BBVA

CRBG

LPLA

UPST

Shares of companies in the broader financial services and banking sectors are trading higher amid overall market strength following the Fed's rate cut, which could drive a rise in spending and lending demand.

Raymond James analyst Patrick Tyler Brown maintains Casella Waste Sys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CWST#NASDAQ">CWST</a>) with a Strong Buy and raises the price target from $121 to $122.

CWST

Raymond James Maintains Strong Buy on Casella Waste Sys, Raises Price Target to $122

BABA

BEKE

BIDU

New Oriental Education & Technology Group

NAAS

NTES

Citigourp Global Markets 2% Protected Notes Linked To The Djia

TCOM

XPEV

YUMC

Shares of US-listed Chinese stocks are possibly trading higher ahead of expectations that the People's Bank of China will cut rates. Also, the sector may be experiencing strength after the Fed cut rates by 50 basis points.

AAPL

Apple shares are trading higher amid overall market strength following the Fed's rate cut.

Morgan Stanley analyst Carlos De Alba maintains MP Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MP#NYSE">MP</a>) with a Equal-Weight and raises the price target from $13.5 to $16.

Morgan Stanley Maintains Equal-Weight on MP Materials, Raises Price Target to $16

Morgan Stanley analyst Carlos De Alba maintains Compañía de Minas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BVN#NYSE">BVN</a>) with a Overweight and lowers the price target from $21 to $18.

Morgan Stanley Maintains Overweight on Compañía de Minas, Lowers Price Target to $18

NIO shares are trading higher following reports suggesting that the company is discounting its Onvo car to compete with Tesla. Also, the stock may be moving higher following the Fed's policy decision to cut rates, which may create optimistic sentiment that the People's Bank of China will cut rates.

BROS

BTBD

CAKE

DASH

KRUS

PLAY

SHAK

WING

Shares of restaurant companies are trading higher following the Fed's rate cut, which could boost industry traffic through an increase in consumer discretionary incomes.

In an aggressive start to its monetary policy easing, the Federal Reserve cut the interest rates by 50 basis points, bringing the fund rates to the 4.75-5% range.
This marked the end of an era of aggressive interest rate hikes to tame &quot;persistent&quot; inflation. The central also indicated two more rate cuts this year, which will bring the Fed funds rate down to 4.4% in 2024.
Following the announcement, the markets&#39; reaction was subdued, and all three major indexes ended in red on Wednesday. On the other hand, indexes related to banks, including the KBW Nasdaq Bank Index and the S&amp;P Banks Select Industry Index closed in green.
The interest rate cut is a positive development for banks like Bank of America (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bac#NYSE">BAC</a>), Citigroup (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/c#NYSE">C</a>) and Comerica (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cma#NYSE">CMA</a>). Banks have been reeling under increasing funding cost pressure. Though higher rates led to a significant jump in banks&#39; net interest income (NII), the same resulted in increased funding costs, which squeezed the net interest margin.
As interest rates come down, funding costs will gradually stabilize and then decline. Hence, this will alleviate pressure on NIM to some extent.
On the other hand, JPMorgan (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jpm#NYSE">JPM</a>) is expected to witness a fall in NII next year. The company&#39;s president and chief operating officer, Daniel Pinto, during the Barclays Global Financial Services Conference on Sept. 10, warned about a potential decrease in the metric in 2025 because of rate cuts.
<h2>What Else Did the Fed Signal?</h2>
In addition to this year&#39;s further reduction in interest rates, the Fed officials, through its dot plot, signaled four more cuts in 2025 and two in 2026.
This will bring the interest rates close to 2.9% by the end of 2026. It is lower than the 3.1% forecasted during the June FOMC meeting. 
Fed&#39;s Dot Plot
<img alt="Federal Reserve" src="https://staticx-tuner.zacks.com/images/articles/charts/52/78412.jpg?v=538394579" />
Image Source: Federal Reserve
Additionally, the central bank came out with the latest summary of Economic Projects. Per the latest SEP data, the U.S. economy is anticipated to grow at the rate of 2% till 2026.
Moreover, the Fed officials noted that &quot;job gains have slowed and the unemployment rate has moved up but remains low.&quot; They lifted their expected unemployment rate to 4.4% for 2024 from the 4% forecasted at the last update in June.
The central bank lowered the inflation target to 2.3% for 2024 from 2.6% predicted in June.
<h2>How Will Banks Be Impacted?</h2>
Apart from the above-mentioned decrease in funding costs, lower rates mean a rise in loan demand. The lending scenario has been muted as the central bank began tightening its monetary policy in March 2022. This had been hurting banks&#39; financials immensely.
As the rates come down, loan demand is gradually expected to improve. The borrowers who have been on the sidelines because of higher rates are now expected to jump in.
Thus, banks including BAC, C, JPM and CMA are expected to benefit from a solid rebound in loan demand.
Lower rates will also result in a gradual improvement in banks&#39; asset quality as borrowers repay loans.
Nonetheless, all of these are not expected to occur immediately, and investors should not expect a total turnaround in banks&#39; financial performance, at least this year.
<a href="https://www.zacks.com/stock/news/2338546/fed-cuts-interest-rates-by-50bps-what-this-means-for-bank-stocks?cid=CS-BENZ-FT-analyst_blog|industry_focus-2338546">To read this article on Zacks.com click here.</a>

Large Cap

Mid Cap

Events

Federal Reserve

Markets

Trading Ideas

Fed Cuts Interest Rates by 50Bps: What This Means for Bank Stocks

Builders FirstSource, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLDR#NYSE">BLDR</a>) shares are trading higher on Thursday. The company appointed Peter Jackson as its next President and CEO and <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/b40935211/builders-firstsource-announces-planned-ceo-and-cfo-transition" rel="noreferrer noopener">Pete Beckmann As CFO, effective November 6, 2024.</a>
Jackson, who is the current CFO, will succeed current CEO Dave Rush, who is retiring after 25 years of service.
Rush will remain on the Board of Directors and serve as a special advisor to ensure a smooth transition.
On the other hand, Pete Beckmann, currently Senior Vice President of Financial Planning &amp; Analysis at Builders FirstSource, will succeed Peter Jackson as CFO.
Beckmann, who has been with Builders FirstSource and its predecessor companies since 1999, has held various finance roles, including leading reporting, forecasting, strategic planning, and capital investment analysis.
Paul Levy, Chair of the Board of Directors, said, &#8220;Peter&#8217;s appointment as the Company&#8217;s next CEO underscores the Board&#8217;s steadfast commitment to excellence in our leadership team, and is the result of a thoughtful succession planning process.&#8221;
&#8220;Peter is a dynamic and innovative leader who has had wide-ranging impact on Builders FirstSource. He brings a strategic, operational, and finance-oriented mindset to his new role, as well as a deep understanding of our history, mission and strategy.&#8221;
Last month, the company&nbsp;reported second-quarter adjusted earnings per share of $3.50,&nbsp;beating the street view of $3.02, and sales of $4.456 billion <a target="_blank" href="https://www.benzinga.com/news/earnings/24/08/40197700/builders-firstsource-q2-eps-beat-lower-sales-and-1b-stock-buyback-more" rel="noreferrer noopener">missed&nbsp;the street view of $4.483 billion</a>.
As of June-end, liquidity was approximately $1.7 billion, consisting of $1.6 billion in net borrowing availability under the revolving credit facility and $0.1 billion cash on hand.
Investors can gain exposure to the stock via&nbsp;Themes US Small Cap Cash Flow Champions ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCF#NASDAQ">SMCF</a>) and Argent Mid Cap ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMID#NASDAQ">AMID</a>).
Price Action: BLDR shares are up 3.09% at $200.53 at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40882613/builders-first-source-other-homebuilder-stocks-rise-with-catalysts-such-as-mortgage" target="_blank" rel="noreferrer noopener">Builders First Source, Other Homebuilder Stocks Rise With Catalysts Such As Mortgage Rates, The Fed, Kamala Harris Plan</a></li>
</ul>

Equities

Management

Movers

AMID

BLDR

SMCF

Builders FirstSource Taps CFO Peter Jackson For Top Role As CEO Dave Rush Plans Retirement

Morgan Stanley analyst Carlos De Alba maintains Vale (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VALE#NYSE">VALE</a>) with a Overweight and lowers the price target from $16 to $15.5.

VALE

Morgan Stanley Maintains Overweight on Vale, Lowers Price Target to $15.5

The well-known cannabis-based pharmaceutical drug Epidiolex, primarily used to treat childhood epilepsy, may offer relief to veterans suffering from Gulf War Illness (GWI), according to new research.
A new study on rats shows the potential of <a href="https://www.benzinga.com/topic/epidiolex">Epidiolex</a>, the FDA-approved cannabidiol (CBD) drug produced by Jazz Pharmaceuticals PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAZZ#NASDAQ">JAZZ</a>)&#8217;s GW Pharmaceuticals, in addressing cognitive, mood and pain-related symptoms of GWI, a condition linked to chemical exposures during the 1990-1991 Gulf War.
The research, conducted by Chinese scientists, was first <a href="https://hemptoday.net/early-study-shows-epidiolex-may-have-potential-as-treatment-for-illness-in-veterans/">reported</a> by&nbsp;Hemp Today.
<h3 class="wp-block-heading">Cognitive And Pain Improvements Observed</h3>
The research, <a href="https://mmrjournal.biomedcentral.com/articles/10.1186/s40779-024-00563-2#Sec23">published</a> in Military Medical Research, reveals that long-term oral administration of CBD could alleviate cognitive impairments, mood disorders and chronic pain.
Rats treated with Epidiolex showed significant improvements in object recognition and memory retention, which are common areas of dysfunction in veterans with GWI. Additionally, CBD treatment helped ease anhedonia— the inability to experience pleasure— and reduced pain sensitivity.
<ul>
<li>Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you&#8217;re serious about the business, you can&#8217;t afford to miss out.</li>
</ul>
GWI, which affects 25% to 32% of the 700,000 veterans who served in Operation Desert Storm, stems from exposure to environmental hazards like pesticides, burning oil wells and chemical agents.
Veterans experience chronic fatigue, muscle and joint pain, gastrointestinal issues, respiratory problems, cognitive dysfunction and headaches. The study highlights CBD's ability to target brain pathways linked to neuroinflammation and oxidative stress, both of which worsen GWI symptoms. In this manner, these findings add to the general notion of cannabis helping Veterans to overcome the consequences of war-related activity.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/22/08/28637449/thc-is-beneficial-for-ptsd-treatment-new-study-reveals">THC Is Beneficial For PTSD Treatment, New Study Reveals</a>
<h3 class="wp-block-heading">Veterans, Cannabis And War-Related Ailments</h3>
Unlike previous treatments such as curcumin or melatonin, Epidiolex proved effective at lower doses, reducing the risk of side effects. The 20 mg/kg dose used in rats equates to about 3.2 mg/kg for humans, offering a more efficient solution compared to other treatments. 
The research also notes that Epidiolex didn't impact motor function, confirming &#8220;an excellent safety profile even when taken long-term in low doses, with no observed harmful effects.&#8221;
Despite these promising results, the study emphasizes the need for further research, especially regarding potential drug interactions. 
While CBD offers hope for veterans with GWI, comprehensive clinical studies are essential before it can become a widespread treatment. 
This study, adds to the growing body of research on CBD showing medical uses for cannabis and war-related illnesses, such as <a href="https://www.benzinga.com/markets/cannabis/24/06/39381895/17-us-veterans-take-their-own-lives-everyday-heres-how-one-cannabis-company-is-trying-to-help">PTSD</a> and <a href="https://www.benzinga.com/24/07/39774432/new-study-shows-high-use-of-medical-cannabis-for-chronic-pain-and-arthritis-in-older-patients">chronic pain</a>.
<ul>
<li>Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/06/39381895/17-us-veterans-take-their-own-lives-everyday-heres-how-one-cannabis-company-is-trying-to-help">17 US Veterans Take Their Own Lives Everyday, Here&#8217;s How One Cannabis Company Is Trying To Help</a></li>
</ul>
Cover: AI generated image

Economics

Media

JAZZ

FDA-Approved Cannabis-Based Drug Shows Promising Results As A Treatment For War Veterans: Study Finds Improvement In Cognitive, Mood, Pain-Related Symptoms

Morgan Stanley analyst Carlos De Alba maintains Freeport-McMoRan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>) with a Overweight and lowers the price target from $60 to $58.

Morgan Stanley Maintains Overweight on Freeport-McMoRan, Lowers Price Target to $58

RBC Capital analyst Drew McReynolds maintains Rogers Communications (TSX:<a class="ticker" href="https://www.benzinga.com/stock/RCI#TSX">RCI</a>) with a Outperform and raises the price target from C$65 to C$66.

TSX:RCI

TSX:RCI.B

RBC Capital Maintains Outperform on Rogers Communications, Raises Price Target to C$66

GRBK

LGIH

LOVE

LSEA

ROCK

TMHC

Shares of housing-related stocks are trading higher after the Fed policy decision to cut rates by 50 basis points, which could help curb housing unaffordability and increase demand.

Analysts have been eager to weigh in on the Real Estate sector with new ratings on Viridien (GB:0RI9 – Research Report) and CA Immobilien Anlagen A...

Analysts Have Conflicting Sentiments on These Real Estate Companies: Viridien (GB:0RI9) and CA Immobilien Anlagen AG (OtherCAIAF)

CAIAF

CA Immobilien Anlagen

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

CA Immobilien Anlagen

News

Latest news for CA Immobilien Anlagen (OTC:CAIAF) Stock